Malignant tumours of many organs may metastasize to the brain and metastatic deposits which give rise to symptoms and signs implicating the nervous system are seldom solitary. In a considerable proportion of cases there are also metastases elsewhere in the body. However, Flavell (1949) reported the case of a patient who had a metastasis in the brain from a primary carcinoma of the lung. The secondary deposit was excised from the temporal lobe and then eight weeks later the lung with the primary tumour was removed. This man was alive and well in 1964, sixteen years after these operations (personal communication from Mr D W C Northfield). Other cases of the removal of an apparently solitary cerebral metastasis as well as the primary tumour have been reported occasionally (see Russell & Rubinstein 1963) .
Some years ago I analysed the autopsy records of a series of 70 patients whose earliest symptoms or signs had pointed to disease of the brain and who had eventually been found to have a primary malignant tumour of some other organ. I examined the fixed brains of these cases, which had been cut into slices 1-0 cm thick, and found that only 12 had a single, macroscopic, nodular deposit of tumour, while the autopsy notes showed that all of these 12 cases had had metastases in other organs. The figure of 12 for cases with a solitary cerebral metastasis is doubtless too optimistic. When Rich & McCordock (1933) made their classical study of the.brains of patients with tuberculous meningitis they had to cut the brains into slices 3 0 mm thick in order to find the smaller caseous foci and there is little doubt that, in my series, thinner slices, transilluminated, Symptoms appeared only two days before death would have revealed that several of the 12 cases which appeared to have solitary metastases, had in fact more than one nodule. A study by Dr L W Duchen, in our Department, has shown that in many cases of mammary carcinoma there are metastatic deposits in the posterior lobe of the pituitary. A histological study of the pituitaries of my 70 cases would probably have revealed a number with metastatic deposits here and have reduced the total with solitary metastases. In addition, a careful histological study of the 12 brains might have revealed the early stages of infiltration of the leptomeninges by tumour cells, the so-called 'carcinomatous meningitis' (Fischer-Williams et al. 1955) .
Tuinours of the lung, breast and kidney are those-which most commonly metastasize to the nervous system, though primary malignant tumours of many organs may do so (see Willis 1952 , Russell & Rubinstein 1963 ). In addition, melanomata at any site not infrequently give rise to cerebral metastases, and I have seen a number with solitary cerebral metastases (Fig 1) .
The most common sites for metastases or secondary deposits are the cerebral hemispheres, followed by the cerebellum and the brain stem (Fig 2) . Metastases actually within the spinal cord are thought to be rare, though masses in the subarachnoid space from extracerebral primary tumours are not uncommonly seen, especially on the cauda equina (Fig 3) . Such intrathecal deposits may give the first clinical signs, suggesting a primary tumour of the spinal cord. In this connexion it is of interest that a primary tumour of the brain or cerebellum when still 'silent' may give rise to intrathecal deposits (the so-called 'seedlings' of gliomas) which look exactly the same, macroscopically, as secondary deposits from an extracerebral tumour and which again may give the first symptoms and signs of neurological disorder. When a brain studded with small secondary deposits is examined it is seen that these lie mainly in the grey matter (Fig 4) , especially in the deepest part of the cortex or in iie basal ganglia. Metastatic deposits, both large and small, are usually well defined and can often be shelled out completely by the neurosurgeon, in this way being quite unlike gliomas. When superficially placed they tend to invade the meninges (as indeed do some malignant gliomas). Both these superficial metastatic tumours and those abutting on the ventricular system tend to shed cells into the cerebrospinal fluid so that when a secondary deposit in the brain is suspected a careful examination of the fluid may be rewarding, malignant cells often being recognizable (Spriggs 1954) .
A point of some practical importance is that an intense cedema may develop in the.-brain surrounding a secondary deposit ( Fig 5) . Although we know that needling a secondary, or even the passage of a needle track near the tumour, may lead to the rapid development of extensive <rdema, so that a whole hemisphere may become cedematous, we have no idea what causes the sudden cedema which may occur spontaneously, just as it may do around a meningioma. In cases of intracranial metastatic tumour all the complications~f .. al space-occupying mass within the skull miay bl seen, tonsillar herniation, hippocampal herniation, cingulate herniation, brain stem hnemorrhages and others. Two forms of involvement of the nervous system by carcinomata are relatively little known. These are carcinomatosis of the meninges or 'carcinomatous meningitis' (Fischer-Williams et a!. 1955) and the so-called 'carcinomatous encephalitis'. Clinically the fAost striking feature of 'carcinomatous meningitis' is headache which is extremely severe and is often associated with relatively insignificant signs. An early sign may be blindness from involvement of the optic nerves. In 'carcinomatous encephalitis' dementia may be the presenting symptom. Pathologically the brain usually looks perfectly normal macroscopically and it is not until it is studied histologically that the diagnosis can be made. In 'carcinomatous meningitis' a layer of tumour cells is seen lining the cerebrospinal pathways and the optic nerves are commonly ensheathed by these cells, a fact which presumably causes the visual disturbance although the exact mechanism by which the visual pathways are damaged is unknown. In 'carcinomatous encephalitis' the small vessels of the brain are cuffed by a layer of tumour cells, which presumably interfere with the passage of oxygen and metabolites to and from the cerebral tissues. In both these conditions it is possible in many cases to make a diagnosis by identifying tumour cells in the cerebrospinal fluid.
Finally, it must be remembered that various forms of degeneration of the nervous system may occur in association with carcinoma of various ...
Fig 6
Transverse section of the spinal cord from a case of carcinoma of the lung. The patient had an almost complete sensory loss and there is complete demyelination ofthe posterior columns organs (especiallycarcinoma of the lung). The sensory neuropathy first described by Denny-Brown in 1948 in which severe loss of nerve cells in the posterior root ganglia leads to extensive sensory loss is probably less rare than is generally thought. In one case which I studied, the loss of cells in the ganglia was almost complete and the consequent degeneration in the posterior columns of the spinal cord ( Fig 6) was more severe than I had seen in any other condition, including tabes dorsalis. Cerebellar degeneration is also not uncommonly associated with carcinoma (Brain et al. 1951) . There is severe loss of Purkinje cells of the cerebellum, with degeneration of parts of the white matter. There is thought to be a myopathy associated with carcinoma (Brain & Henson 1958) , but this is not so clear cut pathologically as are the neuropathies and cerebellar lesions.
At present we have no idea of the real causes of these degenerations of the nervous system which are associated with carcinoma, but it seems most likely that they are due to some metabolic disturbance, presumably caused by the carcinoma.
Professor Sir Brian Windeyer (The Middlesex Hospital, London)
Metastases in the Central Nervous System: Treatment by Radiotherapy and Chemotherapy
The radiotherapist probably sees a high proportion of those patients who develop metastases in the central nervous system for whom any treatment is considered to be applicable. Many of them are already being treated for metastases in other parts of the body and the development of an intracranial or spinal metastasis may be a final stage in the evolution of generalized disease. Sometimes a metastasis in the central nervous system may be the first sign of recurrence after a period of months or years of well-being following an operation such as radical mastectomy or resection of cancer of the lung or apparently successful radiotherapy. This is illustrated by Fig 1 where the patient had had treatment for 
